ATE400264T1 - Methoden zur behandlung von nierenversagen - Google Patents

Methoden zur behandlung von nierenversagen

Info

Publication number
ATE400264T1
ATE400264T1 AT97948333T AT97948333T ATE400264T1 AT E400264 T1 ATE400264 T1 AT E400264T1 AT 97948333 T AT97948333 T AT 97948333T AT 97948333 T AT97948333 T AT 97948333T AT E400264 T1 ATE400264 T1 AT E400264T1
Authority
AT
Austria
Prior art keywords
patient
methods
ferric
accordance
kidney failure
Prior art date
Application number
AT97948333T
Other languages
English (en)
Inventor
Chen Hsing Hsu
Original Assignee
Chen Hsing Hsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26708838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE400264(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chen Hsing Hsu filed Critical Chen Hsing Hsu
Application granted granted Critical
Publication of ATE400264T1 publication Critical patent/ATE400264T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Liquid Crystal Substances (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT97948333T 1996-12-16 1997-11-14 Methoden zur behandlung von nierenversagen ATE400264T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3274596P 1996-12-16 1996-12-16
US08/794,328 US5753706A (en) 1996-12-16 1997-02-03 Methods for treating renal failure

Publications (1)

Publication Number Publication Date
ATE400264T1 true ATE400264T1 (de) 2008-07-15

Family

ID=26708838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948333T ATE400264T1 (de) 1996-12-16 1997-11-14 Methoden zur behandlung von nierenversagen

Country Status (12)

Country Link
US (1) US5753706A (de)
EP (1) EP0959878B1 (de)
JP (2) JP4173553B2 (de)
KR (1) KR100464504B1 (de)
AT (1) ATE400264T1 (de)
AU (1) AU723091B2 (de)
CA (1) CA2272711C (de)
DE (1) DE69738824D1 (de)
ES (1) ES2310417T3 (de)
IL (1) IL130041A (de)
NO (1) NO327148B1 (de)
WO (1) WO1998026776A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753706A (en) * 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
JP2004503301A (ja) * 2000-06-15 2004-02-05 ガンブロ　ルンデイア　アクチーボラグ 透析においてカルシウムのプロファイルを作る方法および装置
US6887897B2 (en) 2001-07-31 2005-05-03 Mission Pharmacal Company Calcium glutarate supplement and phosphorus binder
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
US8592421B2 (en) 2003-08-04 2013-11-26 Valery Khazhmuratovich Zhilov Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
US6903235B2 (en) * 2003-10-08 2005-06-07 Panion & Bf Biotech Inc. Pharmaceutical-grade ferric citrate
US20060046964A1 (en) * 2004-09-02 2006-03-02 Andre Morneau Pharmaceutical formulations and methods
JP2008526771A (ja) * 2004-12-30 2008-07-24 ジェンザイム コーポレーション 高リン酸血症のための亜鉛含有処置
EA018245B1 (ru) 2005-08-18 2013-06-28 Панион Энд Бф Биотех Инк. Органические соединения трехвалентного железа фармацевтического качества, их применение и способы их получения
US8986669B2 (en) * 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
WO2007056405A2 (en) * 2005-11-08 2007-05-18 Genzyme Corporation Magnesium-containing polymers for the treatment of hyperphosphatemia
CA2640763C (en) * 2006-01-30 2016-10-11 Globoasia, Llc Method of reversing, preventing, delaying or stabilizing soft tissue calcification
US7985429B2 (en) 2006-03-03 2011-07-26 C. B. Fleet Company, Inc. Flavored colonic cleansing system
EP2043627A2 (de) * 2006-07-05 2009-04-08 Genzyme Corporation Eisen(ii)-haltige behandlungen für hyperphosphatämie
US7998510B2 (en) 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
US8129430B2 (en) 2007-08-31 2012-03-06 C.B. Fleet Company, Inc. Method of reducing phosphate nephropathy in a mammal
AU2009305602B2 (en) * 2008-10-17 2012-08-16 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient
KR101322259B1 (ko) 2008-10-27 2013-10-28 에스비아이 파마 가부시키가이샤 5-아미노레불린산 혹은 그의 유도체, 또는 그들 염을 유효성분으로 하는 성인병의 예방·개선제
US9387191B2 (en) 2009-07-21 2016-07-12 Keryx Biopharmaceuticals, Inc. Ferric citrate dosage forms
US8822225B2 (en) * 2009-10-01 2014-09-02 Fresenius Medical Care Holdings, Inc. Method of calculating a phosphorus-protein ratio
EP2594277A4 (de) * 2010-07-07 2014-01-01 Japan Tobacco Inc Tablette mit eisencitrat
EP3971162A1 (de) * 2011-01-18 2022-03-23 Japan Tobacco Inc. Eisen(iii)citrat im wesentlichen frei von beta-eisenhydroxidoxid
EA201590062A1 (ru) * 2012-06-21 2016-02-29 Керикс Байофармасьютикалз, Инк. Применение лимонно-кислого железа при лечении пациентов с хронической почечной недостаточностью
PL3003327T3 (pl) 2013-06-05 2018-02-28 Tricida Inc. Protono-wiążące polimery do podawania doustnego
WO2015110968A1 (en) 2014-01-23 2015-07-30 Lupin Limited Pharmaceutical grade ferric citrate and method for its production
US10172882B2 (en) 2014-06-22 2019-01-08 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
AU2015360413B2 (en) 2014-12-10 2021-07-08 Tricida, Inc. Proton-binding polymers for oral administration
JP6206420B2 (ja) * 2015-01-13 2017-10-04 テクノサイエンス株式会社 クエン酸第二鉄を高濃度で含有するゲル状組成物の製造方法
US20180222836A1 (en) 2015-08-05 2018-08-09 Lupin Limited Process for the Preparation of Pharmaceutical Grade Ferric Citrate
JP7071284B2 (ja) 2016-05-06 2022-05-18 トリシダ・インコーポレイテッド 酸塩基障害を処置するためのＨＣｌ結合性組成物およびその方法
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
CA3080651A1 (en) 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
TW202313072A (zh) 2021-05-27 2023-04-01 美商凱立克斯生物製藥股份有限公司 檸檬酸鐵之兒科調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1131360B (de) * 1957-11-26 1962-06-14 Vitarine Company Inc Verfahren zum Stabilisieren von waessrigen Loesungen, die neben Vitamin B noch Vitamin B und Vitamin C enthalten
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
GB2212396A (en) * 1987-12-18 1989-07-26 Procter & Gamble Dietary supplement comprising calcium and delayed release coated iron
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
DE4239442C2 (de) * 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
JPH08198760A (ja) * 1995-01-20 1996-08-06 Japan Organo Co Ltd 経口用リン酸イオン吸着剤
US5753706A (en) * 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure

Also Published As

Publication number Publication date
JP2007217429A (ja) 2007-08-30
NO992936D0 (no) 1999-06-16
AU723091B2 (en) 2000-08-17
KR100464504B1 (ko) 2004-12-31
US5753706A (en) 1998-05-19
DE69738824D1 (de) 2008-08-21
NO992936L (no) 1999-08-13
CA2272711C (en) 2008-04-29
NO327148B1 (no) 2009-05-04
EP0959878B1 (de) 2008-07-09
ES2310417T3 (es) 2009-01-01
IL130041A (en) 2005-08-31
KR20000069414A (ko) 2000-11-25
AU5441998A (en) 1998-07-15
EP0959878A1 (de) 1999-12-01
EP0959878A4 (de) 2002-03-27
JP2001506262A (ja) 2001-05-15
JP4173553B2 (ja) 2008-10-29
WO1998026776A1 (en) 1998-06-25
IL130041A0 (en) 2000-02-29
CA2272711A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
ATE400264T1 (de) Methoden zur behandlung von nierenversagen
Lockwood et al. Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis.
EA199800399A1 (ru) Сульфатные конъюгаты урсодезоксихолевой кислоты и их применение в лечебных целях при воспалительных заболеваниях и других случаях
DE3685853D1 (de) Mittel zur behandlung von knochenkrankheiten.
Broughton et al. Magnesium-deficiency syndrome in burns
Sauder et al. Acute mercury chloride inioxication. effects of hemodialysis and plasma exchange on mercury kinetic
WO2003011225A3 (en) Calcium glutarate supplement and phosphorus binder
Malluche et al. Aluminum-related bone disease
Tori et al. Urolithiasis in children with spinal cord injury
CA2150183A1 (en) Pharmaceutical composition for the treatment of hemorrhoidal diseases
CA2344910A1 (en) Method for treating renal disease, and pharmaceutical composition for treating renal disease
Hanno et al. KAPOSI'S ARCOMA: WITH EXTENSIVE SILENT INTERNAL INVOLVEMENT
ATE198049T1 (de) Behandlung von magen- und darmgeschwüren mit morphogenen
Lacher et al. Sweating treatment for chronic renal failure
NIENHUIS Clinical peritoneal dialysis
Bliss Calciphylaxis: what nurses need to know.
Brunner et al. Chronic Mesenteric Arterial Insufficiency Caused by Vascular Neurofibromatosis.
Rubin et al. A double blind trial of dipyridamole in CAPD
SU1454472A1 (ru) Способ лечени гнойно-фибринозного плеврита
RU2005487C1 (ru) Способ лечения бронхолегочных заболеваний
RU2182003C2 (ru) Способ лечения нарушения энтерогепатической циркуляции желчи у больных с наружным дренированием желчных путей
RU2150277C1 (ru) Лечение констипации методом кишечного лаважа в.а.маткевича
SU1153921A1 (ru) Способ лечени неспецифических эндобронхитов
Weisse Mercury Finally ‘Makes It’
Gibb et al. Survival in Whipple's disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0959878

Country of ref document: EP